These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30910136)

  • 1. Serum anti mullerian hormone and renalase levels in predicting the risk of preeclampsia.
    Jamil Z; Shahid S; Baig E; Ahmad R; Subhani F; Fatima SS
    Taiwan J Obstet Gynecol; 2019 Mar; 58(2):188-191. PubMed ID: 30910136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel marker in pregnant with preeclampsia: renalase.
    Yılmaz ZV; Akkaş E; Yıldırım T; Yılmaz R; Erdem Y
    J Matern Fetal Neonatal Med; 2017 Apr; 30(7):808-813. PubMed ID: 27147460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal serum anti-Müllerian hormone in Sudanese women with preeclampsia.
    Agabain E; Mohamed H; Elsheikh AE; Hamdan HZ; Adam I
    BMC Res Notes; 2017 Jun; 10(1):217. PubMed ID: 28646929
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal serum anti-Müllerian hormone at 11-13 weeks' gestation in the prediction of preeclampsia.
    Birdir C; Fryze J; Vasiliadis H; Nicolaides KH; Poon LC
    J Matern Fetal Neonatal Med; 2015 May; 28(8):865-8. PubMed ID: 24953352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between ovarian reserve and preeclampsia: a cohort study.
    Erfani H; Rahmati M; Mansournia MA; Azizi F; Montazeri SA; Shamshirsaz AA; Ramezani Tehrani F
    BMC Pregnancy Childbirth; 2019 Nov; 19(1):432. PubMed ID: 31752768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Association between plasma levels of soluble leukocyte differentiation antigens CD₄₀/CD₄₀ ligand and kidney damage in preeclamptic patients].
    Qin W; Zhan Y; Ye YH; Li C; Cui XN
    Zhonghua Fu Chan Ke Za Zhi; 2011 Aug; 46(8):582-6. PubMed ID: 22169515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. May maternal anti-mullerian hormone levels predict adverse maternal and perinatal outcomes in preeclampsia?
    Tokmak A; Güney G; Aksoy RT; Guzel AI; Topcu HO; Keçecioğlu TS; Uygur D
    J Matern Fetal Neonatal Med; 2015 Aug; 28(12):1451-6. PubMed ID: 25133554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphism of the renalase gene in gestational diabetes mellitus.
    Fatima SS; Jamil Z; Alam F; Malik HZ; Madhani SI; Ahmad MS; Shabbir T; Rehmani MN; Rabbani A
    Endocrine; 2017 Jan; 55(1):124-129. PubMed ID: 27507673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of anti-Mullerian hormone in the first trimester as a predictor for hypertensive disorders of pregnancy and other adverse pregnancy outcomes.
    Shand AW; Whitton K; Pasfield A; Nassar N; McShane M; Han X; Henry A
    Aust N Z J Obstet Gynaecol; 2014 Jun; 54(3):244-9. PubMed ID: 24588691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum AMH levels in women with a history of preeclampsia suggest a role for vascular factors in ovarian aging.
    Yarde F; Maas AH; Franx A; Eijkemans MJ; Drost JT; van Rijn BB; van Eyck J; van der Schouw YT; Broekmans FJ
    J Clin Endocrinol Metab; 2014 Feb; 99(2):579-86. PubMed ID: 24248187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study.
    Drakopoulos P; van de Vijver A; Schutyser V; Milatovic S; Anckaert E; Schiettecatte J; Blockeel C; Camus M; Tournaye H; Polyzos NP
    Hum Reprod; 2017 Jan; 32(1):208-214. PubMed ID: 27927849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of angiogenesis modulators in pregnant women with pre-eclampsia: a case-control study.
    Mundim GJ; Paschoini MC; Araujo Júnior E; Da Silva Costa F; Rodrigues Júnior V
    Arch Gynecol Obstet; 2016 Feb; 293(2):369-75. PubMed ID: 26205065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of soluble TNF-like weak inducer of apoptosis (sTWEAK) levels to predict preeclampsia in early weeks of pregnancy.
    Shahid S; Khalid E; Fatima SS; Khan GM
    Eur J Obstet Gynecol Reprod Biol; 2019 Mar; 234():165-170. PubMed ID: 30708268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of low ovarian reserve with cardiovascular disease risk: a cross-sectional population-based study.
    de Kat AC; Verschuren WM; Eijkemans MJ; van der Schouw YT; Broekmans FJ
    Hum Reprod; 2016 Aug; 31(8):1866-74. PubMed ID: 27496945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pre-mixing serum samples with assay buffer is a prerequisite for reproducible anti-Mullerian hormone measurement using the Beckman Coulter Gen II assay.
    Han X; McShane M; Sahertian R; White C; Ledger W
    Hum Reprod; 2014 May; 29(5):1042-8. PubMed ID: 24626805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trends in anti-Müllerian hormone concentrations across different stages of pregnancy in women with polycystic ovary syndrome.
    Köninger A; Kampmeier A; Schmidt B; Frank M; Strowitzki T; Kimmig R; Gellhaus A; Mach P
    Reprod Biomed Online; 2018 Sep; 37(3):367-374. PubMed ID: 30146442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Renalase Levels in Adolescents with Primary Hypertension.
    Lemiesz M; Tenderenda-Banasiuk E; Sosnowska D; Taranta-Janusz K; Wasilewska A
    Pediatr Cardiol; 2018 Aug; 39(6):1258-1264. PubMed ID: 29748702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-Müllerian hormone levels and fecundability in women with a natural conception.
    Hvidman HW; Bang AK; Priskorn L; Scheike T; Birch Petersen K; Nordkap L; Loft A; Pinborg A; Tabor A; Jørgensen N; Nyboe Andersen A
    Eur J Obstet Gynecol Reprod Biol; 2017 Oct; 217():44-52. PubMed ID: 28846864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-Mullerian-Hormone during pregnancy and peripartum using the new Beckman Coulter AMH Gen II Assay.
    Köninger A; Schmidt B; Mach P; Damaske D; Nießen S; Kimmig R; Strowitzki T; Gellhaus A
    Reprod Biol Endocrinol; 2015 Aug; 13():86. PubMed ID: 26250904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of first trimester serum afamin levels and three-dimensional placental bed vascularization as a possible screening method to detect women at-risk for adverse pregnancy complications like pre-eclampsia and gestational diabetes mellitus in low-risk pregnancies.
    Tramontana A; Pablik E; Stangl G; Hartmann B; Dieplinger H; Hafner E
    Placenta; 2018 Feb; 62():9-15. PubMed ID: 29405972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.